University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis

Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical condition that can afflict people with a uterus, causing problems like chronic pelvic pain and fertility issues. Endometriosis affects nearly 200 million people worldwide. Getting […]

© 2024 TechCrunch. All rights reserved. For personal use only.